Showing 2,301 - 2,320 results of 3,189 for search '"vaccination"', query time: 0.07s Refine Results
  1. 2301
  2. 2302

    Determination of FMDV 146S particle concentration by spectrometric method during viral RNA quantification by M. I. Doronin, D. V. Mikhalishin, V. A. Starikov, D. A. Lozovoy, Yu. S. El’kina, A. V. Borisov

    Published 2021-01-01
    “…During FMD vaccine production, special attention is paid to the concentration of 146S particles bearing the critical biological features of FMDV and being the main components that have an effect on vaccine immunogenicity. …”
    Get full text
    Article
  3. 2303
  4. 2304

    The Application of Single-Cell RNA Sequencing in Vaccinology by Andrés Noé, Tamsin N. Cargill, Carolyn M. Nielsen, Andrew J. C. Russell, Eleanor Barnes

    Published 2020-01-01
    “…The power of single-cell RNA sequencing offers various opportunities to decipher the immune response to infectious diseases and vaccines. Here, we describe the potential uses of single-cell RNA sequencing methods in prophylactic vaccine development, concentrating on infectious diseases including COVID-19. …”
    Get full text
    Article
  5. 2305

    Canada’s National Advisory Committee on Immunization: Celebrating 50 Years by Shalini Desai, Shainoor J lsmail, Robert Lerch, Bryna F Warshawsky, Ian Gemmill

    Published 2015-01-01
    “…Vaccines have saved more lives than any other innovation in modern medicine. …”
    Get full text
    Article
  6. 2306

    Covid-19 Detection from Chest X-Ray Images and Hybrid Model Recommendation with Convolutional Neural Networks by Furkan Eryılmaz, Hacer Karacan

    Published 2021-12-01
    “…The COVID-19 pandemic, which emerged at the end of 2019, continues to be effective. Although various vaccines have been developed, uncertainties remain over vaccine sharing, supply, storage and effect. …”
    Get full text
    Article
  7. 2307
  8. 2308
  9. 2309

    The Evolution of Dendritic Cell Immunotherapy against HIV-1 Infection: Improvements and Outlook by Hager Mohamed, Vandana Miller, Stephen R. Jennings, Brian Wigdahl, Fred C. Krebs

    Published 2020-01-01
    “…Dendritic cells have thus been recognized as a valuable tool in the development of immunotherapeutic approaches and vaccines effective against HIV-1. The advancements in dendritic cell vaccines in cancers have paved the way for applications of this form of immunotherapy to HIV-1 infection. …”
    Get full text
    Article
  10. 2310
  11. 2311
  12. 2312

    Indirect determination of FMDV 146S component concentration in non-inactivated suspension by comparison of graphs of the second derivative for real-time RT-PCR curves by M. I. Doronin, D. V. Mikhalishin, V. A. Starikov, D. A. Lozovoy, A. V. Borisov

    Published 2020-09-01
    “…In the process of industrial production of FMD vaccines, special attention is paid to the number of whole virions, which have the most important biological properties of FMD virus and are the main components that determine the immunogenicity of vaccine preparations. …”
    Get full text
    Article
  13. 2313
  14. 2314

    Advances in Immunotherapy for Melanoma: A Comprehensive Review by Carmen Rodríguez-Cerdeira, Miguel Carnero Gregorio, Adriana López-Barcenas, Elena Sánchez-Blanco, Beatriz Sánchez-Blanco, Gabriella Fabbrocini, Brunilda Bardhi, Ardiana Sinani, Roberto Arenas Guzman

    Published 2017-01-01
    “…Several types of vaccines, including peptide, viral, and dendritic cell vaccines, are currently under investigation for the treatment of melanoma. …”
    Get full text
    Article
  15. 2315

    Enhanced Porcine Reproductive and Respiratory Syndrome Virus Replication in Nsp4- or Nsp2-Overexpressed Marc-145 Cell Lines by Zhengqin Ye, Zhenbang Zhu, Liangzheng Yu, Zhendong Zhang, Xiangdong Li

    Published 2025-01-01
    “…Porcine reproductive and respiratory syndrome (PRRS) causes significant economic losses to the swine industry. The killed PRRSV vaccine has been reported to be safe and could elicit humoral responses. …”
    Get full text
    Article
  16. 2316
  17. 2317
  18. 2318
  19. 2319

    Antigen Gene Transfer to Human Plasmacytoid Dendritic Cells Using Recombinant Adenovirus and Vaccinia Virus Vectors by Hetty J. Bontkes, Janneke J. Ruizendaal, Marco W. J. Schreurs, Duco Kramer, Chris J. L. M. Meijer, Erik Hooijberg

    Published 2005-01-01
    “…Recombinant adenoviruses (RAd) and recombinant vaccinia viruses (RVV) expressing tumour-associated antigens (TAA) are used as anti-tumour vaccines. It is important that these vaccines deliver the TAA to dendritic cells (DC) for the induction of a strong immune response. …”
    Get full text
    Article
  20. 2320